Clinical Trials Browser

Phase 1/2 × Withdrawn × FED × Clear all

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT06064279 2024-09-19

HAITEN-ICI

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung